These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 23613404)
21. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer]. Kosacka M; Jankowska R Pneumonol Alergol Pol; 2007; 75(4):317-23. PubMed ID: 18080980 [TBL] [Abstract][Full Text] [Related]
22. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma. Ritter JH; Dresler CM; Wick MR Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697 [TBL] [Abstract][Full Text] [Related]
23. Role of immunohistochemistry markers in neoplastic lung lesions. Umakanthan S; Chalapathi Rao AV; Mohammed W J Cancer Res Ther; 2021; 17(6):1382-1388. PubMed ID: 34916368 [TBL] [Abstract][Full Text] [Related]
24. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475 [TBL] [Abstract][Full Text] [Related]
25. Endobronchial ultrasound fine-needle aspiration biopsy of pulmonary non-small cell carcinoma with subclassification by immunohistochemistry panel. Collins BT Cancer Cytopathol; 2013 Mar; 121(3):146-54. PubMed ID: 22927132 [TBL] [Abstract][Full Text] [Related]
26. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance. Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916 [TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148 [TBL] [Abstract][Full Text] [Related]
28. [Cytology of basaloid squamous cell carcinoma and small cell carcinoma of lung: a comparative study]. He SR; Bai YP; Gong H; Di J; Chen L; Dai WD; Hu ST; Liu DG Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):237-42. PubMed ID: 27033386 [TBL] [Abstract][Full Text] [Related]
29. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer. Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744 [TBL] [Abstract][Full Text] [Related]
30. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category. Walia R; Jain D; Madan K; Sharma MC; Mathur SR; Mohan A; Iyer VK; Kumar L Indian J Med Res; 2017 Jul; 146(1):42-48. PubMed ID: 29168459 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Righi L; Graziano P; Fornari A; Rossi G; Barbareschi M; Cavazza A; Pelosi G; Scagliotti GV; Papotti M Cancer; 2011 Aug; 117(15):3416-23. PubMed ID: 21246522 [TBL] [Abstract][Full Text] [Related]
32. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas. Noh S; Shim H Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426 [TBL] [Abstract][Full Text] [Related]
33. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases. Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA Hum Pathol; 2017 Jan; 59():1-9. PubMed ID: 27569293 [TBL] [Abstract][Full Text] [Related]
34. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers. Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792 [TBL] [Abstract][Full Text] [Related]
35. Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas. Sinna EA; Ezzat N; Sherif GM J Egypt Natl Canc Inst; 2013 Dec; 25(4):209-18. PubMed ID: 24207093 [TBL] [Abstract][Full Text] [Related]
36. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. Sigel CS; Moreira AL; Travis WD; Zakowski MF; Thornton RH; Riely GJ; Rekhtman N J Thorac Oncol; 2011 Nov; 6(11):1849-56. PubMed ID: 21841504 [TBL] [Abstract][Full Text] [Related]
37. Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? Bernardi FDC; Bernardi MDC; Takagaki T; Siqueira SAC; Dolhnikoff M Clinics (Sao Paulo); 2018 Oct; 73():e361. PubMed ID: 30379223 [TBL] [Abstract][Full Text] [Related]
38. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens. Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943 [TBL] [Abstract][Full Text] [Related]
39. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens. Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805 [TBL] [Abstract][Full Text] [Related]
40. Lung carcinoma with rhabdoid component. A series of seven cases associated with uncommon types of non-small cell lung carcinomas and alveolar entrapment. Izquierdo-Garcia FM; Moreno-Mata N; Herranz-Aladro ML; Cañizares MA; Alvarez-Fernandez E Histol Histopathol; 2010 Oct; 25(10):1287-95. PubMed ID: 20712013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]